CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia

CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia

The Department’s decision confirms what CPA has consistently warned: Chinese solar companies have been illegally circumventing U.S. trade laws through Southeast Asian shell operations, flooding the U.S. market with dumped and subsidized products directly harming the domestic solar manufacturing industry.

America’s generic drug crisis demands investment, not dependence

America’s Generic Drug Crisis Demands Investment, Not Dependence

The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on foreign manufacturers for generic drugs is at the center of it.

CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System

CPA Applauds President Trump’s “Liberation Day” Tariff Announcement as Essential Reset of Global Trade System

The Trump administration’s decision to impose a permanent 10% baseline tariff on imports from all countries, combined strategically with higher reciprocal tariffs on nations engaging in unfair trade practices, marks a crucial step forward in reindustrializing America and restoring economic strength and security.

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

What the National Institutes of Health Does for the Economy and the Health of Our Citizens

The National Institutes of Health (NIH) is today the main source of new drugs in this country – indeed the world, because America leads in the field. It has a critical importance to America’s health. Less well known is its huge, positive, economic impact.